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ABSTRACT 
Background: There is a paucity of empirical data on the impact of HIV/AIDS on mortality 
in the mining industry in the pre-ART era.  Such data will provide a baseline against which 
the efficacy of antiretroviral treatment can be measured into the future. 
Objectives:  To measure all-cause mortality in a population of platinum miners between 
1992 and 2002, the impact of HIV/AIDS on mortality in this group and to determine the 
pattern of other cause-specific mortality. 
Methods:  This was a primary analysis of mortality in an open cohort of male semi- and 
unskilled workers at a platinum mine. Using Poisson regression, all-cause, HIV/AIDS-
related and other cause-specific mortality rates and rate ratios were calculated by age and 
calendar year.  
Results:  There were 1986 deaths in the cohort of 29954 subjects who contributed 
200657 person years of follow up over the 11 year period of the study.  Crude all-cause 
mortality increased from a base of 5.1 per 1000 person years at risk (pyar) (95% CI 4.2-
6.2) in 1992 to 20.4 per 1000 pyar (95% CI 18.3-22.8) in 2002.  Age-adjusted all-cause 
mortality increased more than three-fold from 1992 to 2002 (RR 3.2, 95% CI 2.5-4.0). The 
excess mortality was attributed to HIV/AIDS-related deaths which increased from 0% in 
1992-1994 to 5.1% of total deaths in 1995 and reached 63.3 % of deaths in 2002.  
Mortality due to other communicable diseases, non-communicable diseases and injuries 
remained stable throughout the study period. 
Conclusion:  The impact of the HIV/AIDS epidemic on mortality in this group of platinum 
mine workers has been profound and comparable to that experienced by the general 
South African population. The data reported here provide a baseline to measure the 
impact of antiretroviral treatment on the future course of mortality due to the epidemic.  
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1.0 INTRODUCTION 
1.1 BACKGROUND 
In South Africa the first cases of acquired immunodeficiency syndrome (AIDS) were 
diagnosed in 1982, heralding the beginning of the first epidemic that was largely confined 
to homosexual men.(1, 2)  By January 1988 a total of 98 cases had been diagnosed,  86% 
of which occurred in homosexual males.(3)  Over the following decade there was slower 
spread to the heterosexual population resulting in a second epidemic similar in 
demographic characteristics and scope to that of other African countries.(2, 4, 5)   
From the outset though, documenting the extent and impact of the epidemic was 
complicated by issues of confidentiality, individual versus community interests, the socio-
political circumstances peculiar to South Africa and the intense stigmatisation associated 
with the disease.(3)  Furthermore, until recently the national death registration system was 
not capable of providing vital statistics for the majority of the population.(6)   
Initially, systematic national surveillance of AIDS was implemented through a system of 
voluntary anonymous reporting of AIDS cases by doctors under the auspices of the 
Department of National Health and Population Development according to procedures 
adopted by the World Health Organisation (WHO).(7)  This approach was clearly subject to 
underreporting and, as tests for HIV antibodies were developed and became generally 
available, voluntary anonymous reporting was replaced in 1990 by a programme of 
human immunodeficiency virus (HIV) seroprevalence surveillance based on annual 
surveys on women attending antenatal clinics across the county.(7-10) 
By 1995 it was estimated that 1.7 million sexually active adults were infected with HIV 
based on antenatal seroprevalence data and in 2000 the WHO estimated that South 
Africa had more people living with the HIV than any other country in the world.(9, 11) 
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1.2 THE IMPACT OF HIV/AIDS ON ADULT MORTALITY 
Prior to the advent of antiretroviral treatment (ART) HIV infection was invariably fatal  with 
a median survival time from seroconversion of about 9 years.(12)  The impact of HIV/AIDS 
on adult mortality has been illustrated by two types of studies: (1) those in which the HIV 
status of individuals is known, thereby allowing direct comparisons to be made between 
infected and uninfected individuals; and (2) studies of national level statistics, where, 
although HIV status of individuals is unknown, strong indirect evidence is provided by 
mortality time trends and characteristic age patterns consistent with a major impact of the 
HIV epidemic.(13) 
1.3 THE IMPACT OF HIV/AIDS ON MORTALITY IN SUB-SAHARAN AFRICA 
Porter and Zaba reviewed the empirical data from studies conducted in the community 
and other settings  in which HIV status was known to provide direct evidence that the 
rising mortality observed in the developing world was caused by HIV.(14)  Estimates of 
survival at 5 years after seroconversion in two African cohorts were very similar at 79% 
and 77% with a median survival estimated at 8.6 years.(12, 15)  Direct data from community 
based studies showed mortality rates for uninfected individuals in four sub-Saharan 
countries of 2-5 deaths per 1000 person years for those in their teens and twenties, 
increasing to 5-17 per 1000 person years for those in thirties and forties.(15-18)  Rates for 
infected individuals, when standardised for age, were considerably higher and more 
variable: mortality rates for infected individuals in their teens varied between 25-45 deaths 
per 1000 person years, rising to 70-120, 90-150 and 90-200 respectively for those in their 
twenties, thirties and forties. 
In one study of factory workers in Tanzania during 1991 to 1996, overall mortality rates 
were 9.0 and 7.8 per 1000 person years for men and women respectively.(19)  Mortality 
attributable to HIV infection, estimated at 5-6 and 4-5 per 1000 person years for men and 
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women respectively, was considerably lower than found in the other sub-Saharan studies 
quoted above, possibly associated with a “healthy worker” effect.   
Blacker reviewed adult mortality trends in sub-Saharan countries with significant levels of 
HIV prevalence using data sources other than those that collect information on HIV status 
(national population censuses and sample surveys, Demographic and Health Surveys 
(DHS), vital registration and longitudinal surveillance systems).(20)  Census and survey 
data from Kenya, Malawi and Zimbabwe showed increasing mortality in the 1990s, 
reversing previous downward trends.  DHS data for over 20 sub-Saharan countries 
showed that most had increasing mortality which was steepest in eastern and southern 
Africa, with high HIV prevalence rates.  Death registration in Zimbabwe, which has 
appreciable levels of HIV, showed increasing adult mortality: age-specific death rates for 
males aged 25 to 49, based on official death registrations with adjustment for 
completeness, increased at least two-fold between 1982 and 1995 with increases of 3.3, 
4.1 and 3.0 times for age groups 30-34, 35-39 and 40-44 respectively.(21)  During the 15-
year period 1982-1997 the conditional probability of death by age 60, given survival to age 
15, rose from 0.31 to 0.65 for males.  
1.4 THE IMPACT OF HIV/AIDS ON MORTALITY IN SOUTH AFRICA 
There are currently no published empirical data from South African studies in the general 
population on survival after HIV seroconversion or comparisons of mortality comparing 
HIV-positive with HIV-negative subjects.  There are however a number of community 
based studies that show increasing adult mortality during the 1990s. 
Tollman et. al. reported a relative increase in mortality over three years from 1992 to 1995 
observed at the Agincourt demographic and health surveillance field site in the 
Bushbuckridge district where all reported deaths were subject to verbal autopsy.(22)  
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Mortality increase at age 24-49 was 23% for both sexes combined with increased death 
rates due to AIDS, pulmonary tuberculosis and chronic diarrhoea. 
Hosegood et. al. reported a sudden and massive increase in adult mortality in a 
demographic surveillance study that included verbal autopsy interviews in rural northern 
Kwa-Zulu Natal in the late 1990s.(23)  By 2000 AIDS with or without tuberculosis was the 
leading cause of death in the study population accounting for 73 and 61% of female and 
male deaths respectively at ages 15-44 years and the probability of dying between the 
ages 15 and 60 was 58% for women and 75% for men.    
Empirical data obtained from routine cause of death data compiled and reported by Stats 
SA and the Population Register administered by the Department of Home Affairs revealed 
that there was a steady increase in adult mortality during the 1990s.(24)  Mortality of 
women aged 25-29 years was 3.5 times higher in 1999/2000 than in 1985.  Mortality in 
young men aged 30-39 doubled over the same period.  Comparing these data to 
projections based on the ASSA600 AIDS and demographic model it was estimated that 
about 40% of adult deaths aged 15-49 that occurred in the year 2000 were due to 
HIV/AIDS and that about 20% of all adult deaths were due to AIDS. (24, 25)  Further 
projections from this study showed that without treatment to prevent AIDS, the number of 
AIDS deaths can be expected to increase within the next 10 years to more than double 
the number of deaths due to all other causes, resulting in 5 to 7 million cumulative AIDS 
deaths in South Africa by 2010.   
Although the completeness of registration of deaths had improved substantially by 1997 
(80% of all deaths to males and 78% of all deaths to females registered(26)), it has been 
suggested that the official mortality statistics for South Africa underreport HIV/AIDS  
deaths with only 39% of HIV/AIDS deaths been reported as such.(27)    
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1.5 THE IMPACT OF HIV/AIDS ON THE SOUTH AFRICAN MINING INDUSTRY 
Williams and Campbell noted that the most important factors leading to severe HIV 
epidemics in Africa - social and political instability, disruption of social support 
mechanisms and family structures, migrancy, high rates of other sexually transmitted 
diseases which accelerate the transmission of the HIV virus and opportunistic infections, 
especially tuberculosis and pneumonia, which increase mortality and morbidity among 
HIV-positive people - characterise the lives of many of the workers employed on South 
African mines.(28)  It may be expected therefore that the impact of HIV/AIDS in the mining 
industry may be higher than the official death statistics reported at the national level. 
The prevalence of HIV infection in gold miners was reported to be between 0.02% and 
3.76% in 1986, depending on geographic area of origin.(29) More recent surveys reported a 
prevalence of HIV infection of 18.0% in the mining industry, the highest in the industrial 
sectors surveyed.(30) In 2002 prevalence rates for HIV infection at a platinum mine were 
estimated to range between 20.4% and 28.8%, with the highest rates amongst the lower 
job categories.(31)  
As experienced in the public and private sectors, HIV infection has placed a significant 
burden on health services in the mining industry.  In the gold mining sector hospitalisation 
and mortality incident rate ratios in a cohort of 1792 HIV-infected miners were 2.9 and 9.2 
respectively compared to HIV-negative miners in a 12 month prospective study where the 
prevalence of HIV infection was 24%.(32)  A recent study on survival in a HIV 
seroconversion cohort of South African gold miners showed that the survival pattern was 
similar to that seen in the West before antiretroviral therapy was available.(33)   
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The economic impact of HIV/AIDS can be considered in terms of direct and indirect costs.  
In 1999 it was estimated that the direct costs of an average set of benefits (including 
medical scheme costs) was expected to double for many schemes by 2005, and triple by 
2010.(34)  It was further estimated that indirect costs (loss of turnover, recruitment/training, 
sick/compassionate leave, motivation/productivity loss, legal costs, and management and 
labour meetings) could add another 10% to the remuneration budget of a typical 
manufacturing company by 2005, and 15% by 2010. 
2.0 MOTIVATION FOR THE STUDY 
By 2003, the year in which ART programmes were first rolled out, the HIV/AIDS epidemic 
in South Africa had matured into the “sick and dying” phase.  Although high levels of HIV 
prevalence have been documented amongst miners, there is little published data on the 
impact of HIV/AIDS on mortality in the mining industry. While it remains to be seen to what 
extent the course of the epidemic will be altered by the advent of ART, a review of 
empirical data on HIV/AIDS mortality will provide policy makers and service providers, 
including mine management, trade unions, government and local health authorities and 
non-governmental organisations, with a baseline against which the impact of ART can be 
measured into the future. 
3.0 STUDY OBJECTIVES 
The objectives of the study are: 
 to measure the trend of all-cause mortality in a population of platinum miners 
between 1 January 1992 and 31 December 2002; 
 to measure the impact of HIV/AIDS on mortality between 1 January 1992 and 31 
December 2002. 
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 to determine other cause-specific mortality according to the South African National 
Burden of Disease Study classification between 1 January 1992 and 31 December 
2002. 
4.0 METHODS 
4.1 STUDY SETTING 
The setting for the study was a large platinum mine in North West Province, South Africa, 
employing about 22000 people in 1992.   
4.2 STUDY DESIGN  
The design was an open cohort comprising all employees working at the mine between 1 
January 1992 and 31 December 2002 and entailed a primary analysis of mortality. 
4.3 MINE POPULATION AND STUDY SUBJECT SELECTION 
4.3.1 MINE POPULATION  
Mine personnel records were used to construct a database containing demographic data 
on all employees who worked at the mine between 1 January 1992 and 31 December 
2002.  This required the merging of an archived personnel database that was operational 
until April 2001 with the current personnel database.  In both systems an employee could 
have multiple company numbers as a result of promotion and/or re-employment.  The 
data were filtered using national identity and passport numbers to identify duplicate and/or 
multiple records for single individuals.  Where duplicate or multiple records were identified, 
the individual’s record was consolidated under the last or current company number. 
The mine employees were classified into two groups as either (1) semiskilled or unskilled 
workers comprising predominantly migrant underground miners, labourers and surface 
plant workers (SUS); or (2) skilled workers comprising artisans and officials (SOF).   
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4.3.2 STUDY SUBJECTS 
Subjects selected for study were all male SUS employees who worked at the mine 
between 1 January 1992 and 31 December 2002.  This group was chosen for study as it 
represented the majority of the mine population (82.7%) and because their medical 
records were available at the mine hospital (where they received free medical aid) for 
establishing cause of death. 
4.3.3 STUDY VARIABLES 
The following variables were extracted from the database for each subject: 
 study number – a unique number randomly assigned for the study 
 date of birth 
 date employed 
 date employment terminated 
 variable indicating reason for termination of employment (death, medical boarding 
or other) 
4.3.4 MEDICAL BOARDING 
As a condition of employment all SUS employees are members of a provident fund co-
funded by the company.  Membership of the provident fund provides a death benefit in the 
form of a lump sum payable to the employee’s next-of-kin in the event of the employee 
dying within 12 months of being medically boarded for a life-threatening illness (“terminal 
illness”).  Personnel records relating to medical boarding did not discriminate between 
medical boarding classified as “terminal illness” or due to other causes.  For the purposes 
of this study it was therefore assumed that all medical boarding was due to “terminal 
illness” and the date of termination (censoring) of all medically boarded employees was 
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extended by 12 months as these employees effectively remained at risk and under 
observation while eligible for the provident fund death benefit.  
4.4 DETERMINING VITAL STATUS  
Vital status was determined by identifying all in-service deaths recorded in the personnel 
database and deaths recorded by the provident fund within one year of termination of 
employment following medical boarding. 
4.5 DATA SOURCES USED TO DETERMINE CAUSE OF DEATH 
The following sources were used to determine cause of death: 
4.5.1 HOSPITAL DEATH REGISTER 
The mine hospital maintains a register of deaths of employees occurring in the hospital.  
Deaths that occur outside of the hospital (e.g. due to motor vehicle accidents, or deaths of 
medically boarded employees) are also recorded in the register when reported to mine 
authorities. 
The death register records cause of death based on the death certificate (original death 
certificates were not available to the investigator), clinical diagnosis of the terminal illness, 
or mode of death in the case of unnatural deaths (e.g. motor vehicle accident, mine 
accident, suicide). 
4.5.2 MEDICAL BOARDING RECORDS 
Mine procedure for medical boarding is a formal process involving the employee, his/her 
union representative, mine management and the medical service.  Records for this 
procedure include a medical report that is submitted to the insurer.  In the case of death 
following medical boarding, the diagnosis recorded in the medical report to the insurer 
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was assumed to be the cause of death, unless information to the contrary (e.g. death from 
accidental cause) was found. 
4.5.3 MEDICAL RECORDS 
Where no cause of death could be found from the above sources, or where the cause of 
death was ill-defined (e.g. “natural causes”, “shock”), the clinical records at the mine 
hospital were reviewed (if available).   
4.6 ICD-10 CODING OF DEATHS 
For the purposes of this study the investigator coded the cause of all deaths according to 
the tenth revision of the International Classification of Diseases, (ICD-10).(35)   
4.6.1 HIV/AIDS RELATED DEATHS 
It is standard practice in the mine health service to establish HIV status in all patients 
presenting with clinical features suggestive of HIV/AIDS-related disease (subject to 
informed consent with pre- and post-test counselling).  Terminology used to record 
HIV/AIDS-related deaths however was not standardised and included the terms AIDS, 
“AIDS-related”, “immune compromised” and “retroviral disease”.  All causes of death 
recorded in the hospital death register or medical boarding records that included these 
terms were recorded as HIV/AIDS-related and assigned ICD-10 codes B20 to B23 where 
sufficient clinical detail was provided, or B24 as default (unspecified human 
immunodeficiency virus [HIV] disease).  Where medical records were reviewed deaths 
were coded as HIV/AIDS-related if a positive HIV test result was documented in the 
record and clinical findings consistent with WHO criteria for staging HIV-1 infections were 
present.(36) 
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4.6.2 CODING ILL-DEFINED CAUSES OF DEATH 
For non-accidental deaths where there was insufficient information to assign a specific 
code, or where clinical records could not be found, ICD-10 code R99 (other ill-defined and 
unspecified cause of mortality) was assigned. 
For accidental deaths where information on mode of death was not available, ICD code 
Y34 (unspecified event, undetermined intent) was assigned. 
4.7 BURDEN OF DISEASE CLASSIFICATION OF MORTALITY 
For the purpose of determining cause-specific mortality, ICD-10 codes were grouped 
according to the South African National Burden of Disease (NBD) list developed for the 
South African NBD study as described by Bradshaw. (37)  In this system mortality is divided 
into three broad groups of causes of death as follows (Appendix A): 
 Group I - pre-transitional causes (communicable diseases, maternal causes, 
perinatal conditions and nutritional deficiencies); 
 Group II - non-communicable causes; 
 Group III - injuries. 
Although HIV/AIDS is part of Group I, it is reported separately here as it is the subject of 
this study. 
4.8 DATA ANALYSIS 
After assigning study numbers and deleting the employee company number field to 
ensure confidentiality, data were analysed using Stata software, version 8.(38)  Standard 
descriptive statistics were used to describe the demographic characteristics of the study 
population.  Individual records were expanded into person years at risk (pyar) by calendar 
year (1992 to 2002) and 5-year age categories (<25, 25-29, 30-34, 35-39, 40-44, 45-49, 
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50-54, 55+).  All-cause, HIV/AIDS-related and other cause-specific mortality rates and rate 
ratios were calculated by age and calendar year.  Analyses used Poisson regression, with 
adjustment for age as a time varying co-variate.   
4.9 ETHICS APPROVAL 
The study protocol was approved by the University of the Witwatersrand Committee for 
Research on Human Subjects (Medical) (R14/49, protocol number M041028, 1/11/04). 
5.0 RESULTS 
5.1 MINE POPULATION CHARACTERISTICS AND OUTCOMES 
The personnel database contained records for 36215 employees who had worked on the 
mine between 1 January 1992 and 31 December 2002 (Table 1).  Male subjects 
comprised the majority of the mine population (n = 35181, 97.1%).  A total of 1914 deaths 
occurred in-service (males 1908, all-cause death rate 8.4 per 1000 pyar; females 6, all-
cause death rate 1.5 per 1000 pyar). There were 29954 male SUS employees (82.7% of 
total population) with 1809 in-service and 177 post-medical boarding deaths (total deaths 
1986, all-cause mortality rate 9.0 per 1000 pyar) and 351 female SUS employees (1.0% of 
total population) with 4 in-service deaths (all-cause mortality rate 2.7 per 1000 pyar).  
There were 5227 male SOF employees (14.4% of total population) with 99 in-service 
deaths (all-cause mortality rate 3.8 per 1000 pyar) and 683 female SOF category 
employees (1.9% of total population) with 2 in-service deaths (all-cause mortality rate 0.8 
per 1000 pyar).  All further analyses refer to the 29953 male SUS workers.  
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Table 1.  Mine population characteristics and outcomes 
Total
population
n (%) 36 215 29 954 (82.7) 351 (1.0) 5 227 (14.4) 683 (1.9)
Age, mean (sd) 35.4 (8.5) 32.9 (9.1) 33.3 (10.3) 29.4 (8.9)
pyar (%) 230 509 200 657 (87.1) 1 471 (0.6) 25 964 (11.3) 2 417 (1.1)
Deaths (%) 2 091 1986* (95.0) 4 (0.2) 99 (4.7) 2 (0.1)
Mortality rate 9.1 9.9 0.02 0.4 0.01
Medical boarding cases (%) 833 797 (95.7) 5 (0.6) 31 (3.7) 0
Medical boarding rate 3.6 4.0 0.02 0.1
SUS, semiskilled and unskilled workers; SOF, skilled workers and officials
*Includes 177 deaths after medical boarding
(%), of total population. Rates are per 1000 pyar
SUS SOF
Males Females Males Females
 
Employees in service or enrolled in 1992 made up the majority of the cohort (67.2%) and 
accounted for 77.8% of deaths (Table 2). There were 1809 in-service deaths and a further 
177 deaths occurred within 12 months of medical boarding, bringing the total number of 
deaths to 1986.     
Table 2.  Deaths by year of entry to cohort 
Year N (%)* n (%)** n (%)** n (%)**
1992 20117 67.2 1402 70.6 143 7.2 1545 77.8
1993 1730 5.8 89 4.5 8 0.4 97 4.9
1994 1323 4.4 76 3.8 5 0.3 81 4.1
1995 1001 3.3 63 3.2 4 0.2 67 3.4
1996 1978 6.6 102 5.1 8 0.4 110 5.5
1997 604 2.0 26 1.3 2 0.1 28 1.4
1998 439 1.5 18 0.9 3 0.2 21 1.1
1999 667 2.2 10 0.5 3 0.2 13 0.7
2000 474 1.6 12 0.6 1 0.1 13 0.7
2001 505 1.7 6 0.3 0 0.0 6 0.3
2002 1116 3.7 5 0.3 0 0.0 5 0.3
Total 29954 100.0 1809 91.1 177 8.9 1986 100.0
* % of total cohort (29954)
** % of total deaths (1986)
Med board, medical boarding
Total cohort In-service Post med board Total
Deaths
 
The number of deaths by calendar year is shown in Table 3.  The number of deaths in 
medically boarded cases increased sharply from 23 (1.2%) in 2000 to 83 (4.2%) in 2002.  
Although the absolute number of in-service deaths peaked in 2000 (259, 13.0%) the total 
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number of deaths continued to increase each year to the end of the study because of 
deaths in medically boarded subjects.  
Table 3.  Deaths, including post-medical boarding, by calendar year 
Year n (%)* n (%) n (%)
1992 0 0.0 97 4.9 97 4.9
1993 2 0.1 113 5.7 115 5.8
1994 2 0.1 120 6.0 122 6.1
1995 1 0.1 117 5.9 118 5.9
1996 3 0.2 130 6.5 133 6.7
1997 0 0.0 155 7.8 155 7.8
1998 0 0.0 167 8.4 167 8.4
1999 2 0.1 176 8.9 178 9.0
2000 23 1.2 259 13.0 282 14.2
2001 61 3.1 234 11.8 295 14.9
2002 83 4.2 241 12.1 324 16.3
Totals 177 8.9 1809 91.1 1986 100.0
* % of total deaths (1986)
med board, medical boarding
Deaths
Post med board TotalIn-service
 
The rate of medical boarding cases remained relatively constant from 1992 to 1999 but 
then increased significantly from 2000 (4.5 per 1000 pyar, age-adjusted RR 1.6, 95% CI 
1.1-2.4) over the last three years to 2002 (13.8 per 1000 pyar, adjusted RR 4.6, 95% CI 
3.3-6.6) (Table 4).   
Table 4.  Medical boarding cases, rates and rate ratios 
Medical
Year pyar boarding Rate RR RR
1992 19009 37 1.9 1 1
1993 18695 55 2.9 1.5 1.0 - 2.3 1.4 0.9 - 2.2
1994 19395 33 1.7 0.9 0.5 - 1.4 0.8 0.5 - 1.3
1995 19456 33 1.7 0.9 0.5 - 1.4 0.7 0.5 - 1.2
1996 19049 64 3.4 1.7 1.2 - 2.6 1.4 0.9 - 2.1
1997 19254 62 3.2 1.7 1.1 - 2.5 1.3 0.9 - 2.0
1998 18527 60 3.2 1.7 1.1 - 2.5 1.3 0.8 - 1.9
1999 17852 31 1.7 0.9 0.6 - 1.4 0.7 0.4 - 1.1
2000 17251 77 4.5 2.3 1.5 - 3.4 1.6 1.1 - 2.4
2001 16296 126 7.7 4.0 2.8 - 5.7 2.7 1.9 - 3.9
2002 15873 219 13.8 7.1 5.0 - 10.0 4.6 3.3 - 6.6
Totals 200657 797 4.0
*Adjusted for age; pyar, person years at risk; RR, rate ratio.
(Rates are per 1000 pyar)
Unadjusted Adjusted*
95%CI 95%CI
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5.2 ALL-CAUSE MORTALITY 
Crude all-cause mortality from 1992 to 2002 is shown in Figure 1.   Mortality rates were 
relatively stable between 1992 to 1995 (5.1-6.1 per 1000 pyar), increasing to 10.0 in 1999 
and to 20.4 per 1000 pyar by 2002. 
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Figure 1.  Crude all-cause mortality (rate per 1000 pyar, 95% confidence intervals) 
by calendar year: 1992-2002 
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Crude all-cause mortality rates, standardised for age, are shown in Table 5.   Age-
standardisation resulted in slightly higher rates compared to crude rates for years 1992 to 
1996 and thereafter slightly lower rates (2002, 18.7 versus 20.4).   
Table 5.  Crude and age-standardised all-cause mortality rates by calendar year 
Year pyar Deaths Rate Rate
1992 19009 97 5.1 4.2 - 6.2 5.7 4.5 - 6.9
1993 18695 115 6.2 5.1 - 7.4 6.6 5.4 - 7.9
1994 19395 122 6.3 5.3 - 7.5 6.9 5.6 - 8.1
1995 19456 118 6.1 5.1 - 7.3 6.4 5.2 - 7.5
1996 19049 133 7.0 5.9 - 8.3 7.1 5.9 - 8.3
1997 19254 155 8.1 6.9 - 9.4 8.0 6.7 - 9.3
1998 18527 167 9.0 7.8 - 10.5 8.7 7.4 - 10.1
1999 17852 178 10.0 8.6 - 11.6 9.6 8.2 - 11.0
2000 17251 282 16.4 14.6 - 18.4 15.5 13.7 - 17.4
2001 16296 295 18.1 16.2 - 20.3 17.0 14.9 - 19.0
2002 15873 324 20.4 18.3 - 22.8 18.7 16.5 - 20.8
200657 1986 9.9 9.5 10.3
pyar, person years at risk; CI, confidence interval
(Rates are per 1000 pyar)
Age-standardised
95% CI95% CI
Crude rates
 
All-cause age-specific mortality rates and rate ratios are shown in Table 6.  All-cause 
mortality increased with age from 5.9 /1000 pyar for under 25 years to 18.8/1000 pyar for 
55 years and older.  Mortality rate ratios for age groups 25 to 39 years were not 
significantly increased compared to under 25 year olds (0.9-1.2) but increased 
significantly and progressively for age groups over 40 years. 
Table 6.  All-cause age-specific mortality rates and rate ratios by age: 1992-2002 
Age pyar Deaths Rate RR
<25 5060 30 5.9 4.1 - 8.5 1
25-29 15205 84 5.5 4.5 - 6.8 0.9 0.6 - 1.4
30-34 31982 173 5.4 4.7 - 6.3 0.9 0.6 - 1.3
35-39 48128 348 7.2 6.5 - 8 1.2 0.8 - 1.8
40-44 45153 477 10.6 9.7 - 11.6 1.8 1.2 - 2.6
45-49 28669 413 14.4 13.1 - 15.9 2.4 1.7 - 3.5
50-55 16762 279 16.6 14.8 - 18.7 2.8 1.9 - 4.1
>55 9698 182 18.8 16.2 - 21.7 3.2 2.2 - 4.7
Totals 200657 1986 9.9 9.5 - 10.3
pyar, person years at risk; RR, rate ratio; CI, confidence interval
(Rates are per 1000 pyar)
95% CI95% CI
Crude rates Rate ratios
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All-cause age-specific mortality rates by calendar year are shown in Figure 2.  Mortality 
rates increased over the study period for all age groups over 25 years of age. 
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Figure 2.  All-cause age-specific mortality rates by calendar year: 1992-2002 
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Crude and age-adjusted all-cause mortality rates and rate ratios by calendar year are 
shown in Table 7.  Unadjusted rate ratios for years 1993 to 1995 were not significantly 
different from 1992 baseline but thereafter increased significantly from 1996 (RR 1.4, 95% 
CI 1.1-1.8) to 2002 (RR 4.0, 95% CI 3.2-5.0).  After adjusting for age, estimates of 
mortality rate ratios were slightly decreased and reached significance in 1997 compared 
to1996 for unadjusted rates.   
Table 7.  Crude and age-adjusted all-cause mortality rate ratios by calendar year 
Year pyar Deaths Rate RR RR
1992 19009 97 5.1 1 1
1993 18695 115 6.2 1.2 0.9 - 1.6 1.2 0.9 - 1.5
1994 19395 122 6.3 1.2 0.9 - 1.6 1.2 0.9 - 1.5
1995 19456 118 6.1 1.2 0.9 - 1.6 1.1 0.8 - 1.4
1996 19049 133 7.0 1.4 1.1 - 1.8 1.2 1.0 - 1.6
1997 19254 155 8.1 1.6 1.2 - 2.0 1.4 1.1 - 1.8
1998 18527 167 9.0 1.8 1.4 - 2.3 1.5 1.2 - 2.0
1999 17852 178 10.0 2.0 1.5 - 2.5 1.7 1.3 - 2.1
2000 17251 282 16.4 3.2 2.5 - 4.0 2.7 2.1 - 3.4
2001 16296 295 18.1 3.5 2.8 - 4.5 2.9 2.3 - 3.6
2002 15873 324 20.4 4.0 3.2 - 5.0 3.2 2.5 - 4.0
 pyar, person years at risk; RR, rate ratio; CI, confidence interval.
(Rates are per 1000 pyar)
Adjusted for ageUnadjusted
95%CI 95%CI
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Figure 3 shows all-cause age-specific (25-54 years) mortality rates for years 1997-2002 
(solid lines) with South African rates for males (dashed lines) for comparison.(26)  In 
general the observed trend in age-specific all-cause mortality rates was similar to the 
reported national rates for males.  
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Figure 3.  All-cause age-specific mortality rates compared to South African national 
rates: 1997-2002 
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5.3 CAUSE-SPECIFIC MORTALITY 
Crude cause-specific mortality rates by calendar year for HIV/AIDS, NBD groups and 
unknown causes are shown in Figure 4 and Table 8.   
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Figure 4.  Crude cause-specific mortality rates by calendar year: 1992-2002 
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Table 8.  Crude cause-specific mortality rates 
Total
Year pyar deaths n Rate n Rate n Rate n Rate n Rate
1992 19009 97 0 - 6 0.3 11 0.6 44 2.3 36 1.9
1993 18695 115 0 - 5 0.3 14 0.7 61 3.3 35 1.9
1994 19395 122 0 - 8 0.4 17 0.9 69 3.6 27 1.4
1995 19456 118 6 0.3 6 0.3 31 1.6 60 3.1 16 0.8
1996 19049 133 16 0.8 12 0.6 28 1.5 57 3.0 20 1.0
1997 19254 155 26 1.4 20 1.0 30 1.6 66 3.4 13 0.7
1998 18527 167 56 3.0 10 0.5 27 1.5 63 3.4 11 0.6
1999 17852 178 74 4.1 9 0.5 31 1.7 47 2.6 16 0.9
2000 17251 282 132 7.7 16 0.9 38 2.2 68 3.9 29 1.7
2001 16296 295 164 10.1 13 0.8 33 2.0 59 3.6 26 1.6
2002 15873 324 205 12.9 26 1.6 25 1.6 46 2.9 22 1.4
Totals 200657 1986 679 4.7 131 0.7 285 1.4 640 3.2 251 1.3
pyar, person years at risk
(Rates are per 1000 pyar)
UnknownNBD Grp IHIV/AIDS NBD Grp II NBD Grp III
 
5.3.1 HIV/AIDS RELATED MORTALITY RATES 
No HIV/AIDS-related deaths occurred in subjects under the age of 25 years. There were 
no HIV/AIDS-related deaths reported in 1992, 1993 or 1994.  HIV/AIDS-related deaths, 
first recorded in 1995 (n=6, rate 0.4 per 1000 pyar), increased progressively to 2002 (n= 
205, rate 12.9 per 1000 pyar) (p for trend < 0.01).  Figure 5 shows HIV/AIDS-related 
deaths as a percentage of total deaths from all causes compared to adult deaths 
estimated from the ASSA600 model.(24)  HIV/AIDS-related deaths in this study increased 
rapidly from 5.1% of total deaths in 1995 to 63.3% in 2002 at a rate similar to that 
predicted by the ASSA600 model. 
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Figure 5.  HIV/AIDS-related deaths as percentage of total deaths, compared to adult 
deaths predicted from ASSA600(24)  
 
HIV/AIDS-related mortality rates and rate ratios by age are shown in Table 9.  HIV/AIDS-
related mortality rates increased across age groups from 2.0 per 1000 pyar for age 25-29 
to 8.2 per 1000 pyar for age 55 years and older.  However, compared to those aged 25-29 
years, the increase in rate ratios was significant only for age 40 and older.   
Table 9.  HIV/AIDS mortality rates and rate ratios by age 
Age* pyar Deaths Rate RR
25-29 9683 19 2.0 1
30-34 18100 53 2.9 1.5 0.9 - 2.5
35-39 32628 101 3.1 1.6 1.0 - 2.6
40-44 35480 181 5.1 2.6 1.6 - 4.2
45-49 23273 154 6.6 3.4 2.1 - 5.4
50-54 12854 107 8.3 4.2 2.6 - 6.9
55+ 7839 64 8.2 4.2 2.5 - 6.9
Totals 143558 679 4.7
*Note: there were no AIDS deaths in subjects <25 years of age
pyar, person years at risk; RR, rate ratio; CI, confidence interval
(Rates are per 1000 pyar)
95% CI
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Unadjusted rate ratios for crude HIV/AIDS-related mortality increased significantly from 
2.7 (95% CI 1.1-7.0) in 1996 to 41.9 (95% CI 18.6-94.3) in 2002 (Table 10) and remained 
highly significant after adjusting for age (using 1995 as a baseline). 
Table 10.  Crude and age-adjusted HIV/AIDS mortality rate ratios by calendar year 
Unadjusted
Year pyar Deaths Rate RR 95%CI RR 95%CI
1992 19009 0 - - - - - - -
1993 18695 0 - - - - - - -
1994 19395 0 - - - - - - -
1995 19456 6 0.3 1 1
1996 19049 16 0.8 2.7 1.1 - 7.0 2.7 1.1 - 6.9
1997 19254 26 1.4 4.4 1.8 - 10.6 4.3 1.8 - 10.4
1998 18527 56 3.0 9.8 4.2 - 22.7 9.4 4.1 - 21.9
1999 17852 74 4.1 13.4 5.8 - 30.9 12.7 5.5 - 29.2
2000 17251 132 7.7 24.8 10.9 - 56.2 23.0 10.1 - 52.0
2001 16296 164 10.1 32.6 14.5 - 73.7 29.5 13.1 - 66.7
2002 15873 205 12.9 41.9 18.6 - 94.3 37.4 16.6 - 84.6
Totals 143558 679
* Adjusted for age.
pyar, person years at risk; RR, rate ratio; CI, confidence interval.
(Rates are per 1000 pyar)
Adjusted*
 
The distribution of HIV/AIDS-related deaths by ICD-10 codes is shown in Table 11.  ICD-
10 code B24 (unspecified HIV disease) accounted for 283 (41.7%) of the HIV/AIDS-
related deaths.  Of the remaining, the majority (348, 51.3%) were due to ICD-10 code B20 
(infectious and parasitic diseases) of which 168 (24.7%) were due to tuberculosis (data 
not shown).  
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Table 11.  Number of HIV/AIDS deaths by ICD-10 codes 
ICD 10 Code n (%) 1995 1996 1997 1998 1999 2000 2001 2002
B20 348 51.3 3 13 21 39 42 68 76 86
B21 9 1.3 2 2 2 3
B22 9 1.3 4 1 3 1
B23 29 4.3 10 1 18
B24 283 41.7 3 3 4 11 31 49 85 97
C46 1 0.1 1
Total 679 6 16 26 56 74 132 164 205
B20: HIV disease resulting in infectious and parasitic diseases
B21: HIV disease resulting in malignant neoplasms
B22: HIV disease resulting in other specified diseases
B23: HIV disease resulting in other conditions 
B24: Unspecified human immunodeficiency virus [HIV] disease
C46: Kaposi's sarcoma
Total Year
 
5.3.2 NON-HIV/AIDS RELATED MORTALITY RATES 
Mortality rates for NBD group I conditions remained relatively unchanged throughout the 
study period but increased significantly in 2002 (n=26, rate 1.6 per 1000 pyar, RR 3.3, 
95% CI 1.3-8.0).  Mortality rates for NBD group II conditions were stable between 1992 
and 1994 but thereafter fluctuated, reaching a peak in 2000 (n=38, rate 2.2, RR=2.7, 95% 
CI 1.4-5.3).  There was no significant trend in death rates or rate ratios for NBD group III 
conditions. 
Causes of death (other than HIV/AIDS-related) for NBD group I, II and III, by calendar 
year, are summarised in Table 12. In NBD group I (communicable diseases, excluding 
HIV/AIDS-related causes), tuberculosis (42.7%) and respiratory infections (40.5%) 
accounted for the majority (83.2%) of deaths (Table 12(a)). 
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Table 12.  Causes of death by National Burden of Diseases classification 
(a) National Burden of Disease Group I: Communicable diseases
n (%) 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Tuberculosis 56 42.7 2 3 1 5 4 12 3 4 6 6 10
Respiratory infections 53 40.5 2 2 5 1 7 6 6 3 4 4 13
Septicaemia 8 6.1 1 1 1 3 1 1
Diarrhoeal diseases 6 4.6 1 1 1 1 2
Bacterial menigitis 6 4.6 2 1 2 1
Other causes 2 1.5 1 0 0 0 0 1 0 0 0 0 0
Total 131 6 5 8 6 12 20 10 9 16 13 26
(b) National Burden of Disease Group II: Non-communicable diseases
n (%) 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Malignant neoplasms 109 38.246 7 11 8 19 7 9 5 7 14 11 11
Cardiovascular 76 26.667 3 3 2 2 9 8 8 17 12 6 6
Digestive 35 12.281 1 0 2 4 4 4 5 3 5 5 2
Genito-urinary 22 7.7193 3 2 3 3 5 1 3 2
Respiratory 18 6.3158 0 0 2 4 2 2 1 0 2 3 2
Nervous system disorders 10 3.5088 0 0 0 0 2 3 1 0 0 4 0
Diabetes mellitus/endocrine 15 5.2632 0 0 0 0 1 1 2 3 2 2 4
Total 285 11 14 17 31 28 30 27 31 38 33 25
(c) National Burden of Disease Group III: Injuries
n (%) 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Road traffic accidents 253 39.531 21 22 33 22 22 26 24 20 27 28 8
Homicide 183 28.594 6 16 11 17 18 13 27 18 23 15 19
Mining accidents 102 15.938 10 11 13 11 6 12 7 4 8 7 13
Other unintentional 36 5.625 0 5 7 4 5 8 1 1 2 2 1
Suicide and self-inflicted 53 8.2813 2 2 4 5 5 7 3 5 8 6 6
Undetermined 13 2.0313 5 5 1 1 1
Total 640 44 61 69 60 57 66 62 48 68 58 47
 
The majority of deaths in NBD group II (non-communicable diseases) were due to 
malignant neoplasm (38.2%) and cardiovascular conditions (26.7%) (Table 12(b)).  Nearly 
a third of deaths over the 11-year period were due to injuries (640/1986) (Table 12(c)). 
Road traffic accidents (39.5%) and homicides (28.6%) accounted for the majority of these 
deaths. There were 102 mining accidents, which contributed 15.9% of deaths due to injury 
and 5.1% (102/1986) of all deaths. 
A specific cause of death could not be determined in 251 of the 1346 deaths (13.3%) 
attributed to natural causes (NBD groups I and II) because of insufficient clinical 
information and/or unavailability of records.  In the case of unnatural causes of death 
(NBD group III) the mode of death could not be determined in 13 of the 640 deaths 
(2.0%).  
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6.0 DISCUSSION 
This study provides insight into the evolution and impact of the HIV/AIDS epidemic from 
before the first deaths due to HIV/AIDS were recorded until antiretroviral therapy first 
became available to a large cohort of male workers at a platinum mine in North West 
Province.  Ascertainment of vital status was complete for subjects while in service at the 
mine and included deaths that occurred within 12 months after employment was 
terminated for medical reasons.  The specific cause was known for the majority of deaths 
(86.7%).  
6.1 ALL-CAUSE MORTALITY 
All-cause age-adjusted mortality remained relatively stable from 1992 to 1995 but 
thereafter increased significantly reaching 20.4 per 1000 pyar by 2002.   There is 
surprisingly little data from South Africa with which this finding can be compared. 
Tollman et. al. found that all-cause mortality for adult males age 20-49 years increased by 
25% in roughly 2 years between the period 1992-1993 and 1994-1995 in the 
Bushbuckridge area.(22)  This increase was not statistically significant and was very similar 
to the increase in all-cause mortality in the present study (24.6%; from 5.7% in 1992 to 
7.1% in 1996).  The slight difference may be explained by differences in age distribution 
and by the fact that the platinum miners had free access to comprehensive health care 
services. 
Hosegood et. al. reported a sharp increase in all-cause adult mortality in rural KwaZulu 
Natal for the year 2000 compared to the period 1982-1997 determined by the orphanhood 
method applied to their study population and the 1996 Census of South Africa.(23)  
Mortality rates in their study were considerably higher (46 to 152%) compared to the 
corresponding year of the present study.  This finding is perhaps not entirely unexpected 
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considering that all-cause mortality in KwaZulu Natal has been shown to be higher than in 
all the other provinces.(39)  
Dorrington et. al., using death registration data reported to the Department of Home 
Affairs and taking into account completeness of registration of deaths, estimated that 
premature adult mortality (indicated by the probability of a 15 year old dying before the 
age of 60) would begin increasing from 1996 and more than double to as high as 80% by 
2010.(24)  While the format of these data does not allow direct comparison to the present 
study, the year of onset of increasing all-cause mortality was very similar to that found in 
the present study (1996 versus 1997). 
More recent death registration data published by Stats SA(26) allows direct comparison of 
national all-cause age-specific mortality with the present study for the period 1997 to 2002 
(Figure 3).  In general, mortality rates increased in a similar pattern over increasing age 
groups.  However, except for age group 50-54 years in 2002, annual age-specific mortality 
rates observed in the present study (solid lines) were generally lower than reported for the 
general population (dashed lines).  This finding could be explained by the fact that the 
population studied was a working population with free access to comprehensive medical 
services as well as the healthy worker effect 
In the present study age-specific mortality (Table 6) showed a significant increase for age 
groups 40-44 and older only.  It has been shown that median survival is strongly 
associated with age at HIV seroconversion: 11.5 years for those aged 15-24 at 
seroconversion versus 6.3 years for those older than 45 years.(33)   
All-cause age-specific mortality observed in the present study for 25 to 49 year olds in 
2002 was very similar to that reported for males in Zimbabwe in 1995.(21)   
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6.2 CAUSE-SPECIFIC MORTALITY 
6.2.1 HIV/AIDS RELATED MORTALITY 
The increase in all-cause mortality was entirely attributable to HIV/AIDS-related deaths 
(Figure 4).  Given that HIV seroprevalence rates in gold miners were as low as 0.02% in 
1986(29) and that by 2002 the seroprevalence rate for HIV in the study population was 24% 
(data for platinum miners not available before 2002), and taking into consideration that 
median time from HIV seroconversion to death before the advent of generally available 
antiretroviral therapy (i.e. the time period of this study) is about 10 years(12, 33), this finding 
is not unexpected.   
By the year 2001 HIV/AIDS-related mortality exceeded all other causes of death 
combined.  For years 1998 to 2000 HIV/AIDS-related deaths as a percentage of total 
deaths in the present study were higher than estimated by the ASSA600 demographic 
model for the general population (Figure 5).(24)  Given that mortality rates for women are 
higher than for men in the ASSA600 model, the difference between HIV/AIDS-related 
compared to total deaths for men between the present study and that estimated by the 
ASSA600 model may even be greater.  
More than half of the HIV/AIDS-related deaths (51.3 %) were due to infectious diseases, 
predominantly tuberculosis and pneumonia.  Tuberculosis accounted for 168 of the 
HIV/AIDS-related deaths. Cause specific HIV/AIDS deaths were not analysed in more 
detail as this was not the objective of the research.  
6.2.2 NON-HIV/AIDS RELATED MORTALITY 
Mortality rates classified according to NBD groups, excluding HIV/AIDS-related deaths, 
showed no systematic trend over the study period (Figure 4).  This finding is surprising 
considering that a number of demographic models (including the ASSA600 model) used 
to estimate the AIDS epidemic assume a decline in non-AIDS mortality and supports the 
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opinion of Dorrington et. al. that adult mortality from non-AIDS causes has probably not 
declined over the past 15-20 years.(40)   
Mortality rates and rate ratios for NBD group I conditions (infectious diseases excluding 
HIV/AIDS) remained unchanged over the study period except for the last year (RR 3.3, 
95% CI 1.3-8.0).  Respiratory infections, septicaemia, diarrhoeal diseases and bacterial 
meningitis were all recorded more frequently from 1997 onwards (Table 12(a)).  These 
conditions have been recognised to contribute to misclassification of HIV/AIDS-related 
deaths and may account for some misclassification of HIV/AIDS-related deaths in the 
present study in cases where individuals refused HIV testing.(27) 
Mortality rates and rate ratios for NBD group II conditions (non-communicable diseases) 
showed somewhat more fluctuation being significantly increased above the 1992 baseline 
for four of the last six years of the study.  Again, it is possible that some misclassification 
of HIV/AIDS-related deaths occurred due to misreporting cause of death. 
Mortality rates and rate ratios for NBD group III conditions (injuries) remained unchanged 
over the study period except for a slight rise in 2000 (RR 1.6, 95% CI 1.1-2.4).  This is a 
disappointing finding as safety, both on the job and at home, is an issue taken very 
seriously within the mining industry.    
6.3 STRENGTHS OF THE STUDY 
The strengths of this study include the following: 
 there was no possibility of selection bias as the entire population of male semi- 
and unskilled workers, representing more than 80% of the total mine population, 
was studied; 
 deaths within one year of medical boarding were included in the study – without 
follow-up of medically boarded subjects the deaths due to HIV/AIDS-related 
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conditions would have been significantly underestimated as increasing numbers of 
workers elected to spend their last months at home with their families; 
 the study period was over a long time period from before the first HIV/AIDS-related 
deaths were recorded up until ART became freely available. 
 the study took into account possible confounding by age, through presenting age-
standardised rates and age-adjusted RRs. 
6.4 LIMITATIONS OF THE STUDY  
Limitations of the study include: 
 the fact that cause of death was unknown in 251 (18.6%) cases of NBD group I 
and II conditions and 13 cases (2.0 %) of NBD group III conditions.  However, 
these deaths were relatively evenly distributed over the study period (Figure 4) and 
are unlikely to have introduced significant bias although it is possible that some of 
these deaths could have been HIV/AIDS-related; 
 the possibility of misclassification bias due to incorrect classification of cause of 
death.(27)   
 the findings of the study may be an underestimate of the true HIV/AIDS mortality 
rate because cause of death was not available in 251 men.  
 the findings of the study may not be generalisable to the non-working portion of the 
South African population. The healthy worker effect and access to good quality 
medical services might reduce the impact of HIV/AIDS on mortality. 
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6.5 CONCLUSION 
The impact of HIV/AIDS on mortality was striking.  This study provides important new 
empirical data on the evolution and natural history of the HIV/AIDS epidemic in the mining 
industry prior to the roll out of freely available antiretroviral treatment and provides a 
baseline for assessing the long-term efficacy of antiretroviral treatment into the future. 
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7.0 APPENDIX A  
South African Burden of Disease List 
Category  SABOD # SA BOD list ICD-10 CODES 
I    Communicable 
A00-A99, B00-B99, C46, D50-D53, D64, E00-E02, E40-E46, 
E50-E64, G00, G03, H65-H66, J00-J22, J90, N70-N73, O00-
O99, P00-P96 
      
I A   Infectious and Parasitic A00-A99, B00-B99, C46, G00, G03, J90, N70-N73 
I A ZA 1 Tuberculosis A15-A19, B90, J90 
I A ZA 2 STDs excluding HIV A50-A64, N70-N73 
I A ZA 2a Syphilis A50-A53 
I A ZA 2b Other STDs A54-A64, N70-N73 
I A ZA 3 HIV/AIDS B20-B24, C46 
I A ZA 4 Diarrhoeal Diseases A00-A04, A06-A09 
I A ZA 5 Childhood Vaccine Preventable) cluster A33-A37, A80, B03, B05-B06, B91 
I A ZA 5a Pertussis A37 
I A ZA 5b Polio A80, B91 
I A ZA 5c Diptheria A36 
I A ZA 5d Measles B05 
I A ZA 5e Tetanus A33-A35 
I A ZA 5f Rubella B06 
I A ZA 6 Bacterial Meningitis and meningococcemia A39, G00, G03 
I A ZA 7 Hepatitis B15-B19 
I A ZA 8 Malaria B50-B54 
I A ZA 9 Schistosomiasis and other tropical diseases B55-B56, B65, B74 
I A ZA 10 Leprosy A30, B92 
I A ZA 11 Intestinal Parasites (nematodes) B76-B81 
I A ZA 12 Septicemia A40-A41 
I A ZA 13 Other infectious and parasitic 
A05, A20-A28, A31 ,A32, A38, A42-A49, A65-A69, A70-A74, 
A75-A79, A81-A89, A90-A99, B00-B02, B04, B07-B09, B25-
B34, B35-B49, B57-B64, B66-B73, B75, B82-B89, B94-B99 
      
I B   Respiratory infections J00-J06, J10-22, H65-H66 
I B ZA 14 Lower respiratory infections J10-J18, J20-J22 
I B ZA 15 Upper respiratory infections J00-J06 
I B ZA 16 Otitis media H65-H66 
      
I C   Maternal Conditions O00-O99 
I C ZA 17 Maternal haemorrhaoe O20, O44-O46, O67, O72 
I C ZA 18 Maternal sepsis O85-O86 
I C ZA 19 Hypertension in pregnancy O10-O16 
I C ZA 20 Obstructed Labour O64-O66 
I C ZA 21 Abortion O00-O08 
I C ZA 22 Other maternal O21-O29, O30-O43, O47-O48, O60-O63,O68-O71, O73-O75, O80-O84, O87-O92, O95-O99 
      
I 0   Perinatal Conditions P00-P96 
I 0 ZA 23 Low birth weight P05-P07, P22 
I 0 ZA 24 Birth asphyxia and trauma P03, P10-P15, P20-P21 
I 0 ZA 25 Other perinatal respiratory conditions P23-P28 
I 0 ZA 26 Neonatal infections P35-P39 
I 0 ZA 27 Other perinatal P00-P02, P04, P08, P29, P50-P61, P70-P94, P96 
     III defined P95 
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I E   Nutritional deficiencies D50-D53 D64 E00-E02 E40-E46 E50-E64 
I E ZA 28 Protein-calorie malnutrition E40-E46 
I E ZA 29 Deficiency anemia’s D50-D53, D64 
I E ZA 30 
Other nutritional deficiencies including pellagra 
and 
vitamin A deficiency 
E00-E02, E50-E64 
      
II    Non-Communicable Disease 
C00-C45, C47-C97, D00-D48, D55-D63, D65-D89, E03-E07, 
E10-E14, E15-E34, E65-E90, F00-F99, G04-G99, H00-H63, 
H68-H95, I00-I99, J30-J89, J92-J98, K00-K93, L00-L98, 
M00-M99, N00-N64, N75-N99, Q00-Q99, R00-R95 
      
II F   Malignant Neoplasms C00-C45, C47-C97 
II F ZA 31 Mouth and Oropharynx C00-C14 
II F ZA 32 Esophagus C15 
II F ZA 33 Stomach C16 
II F ZA 34 Colo-rectal C18-C21 
II F ZA 35 Liver C22 
II F ZA 36 Pancreas C25 
II F ZA 37 Larynx C32 
II F ZA 38 Trachea/bronchi/lung C33-C34 
II F ZA 39 Bone and connective tissue C40-C41, C4,7 C49 
II F ZA 40 Melanoma C43 
II F ZA 41 Other skin cancer C44 
II F ZA 42 Breast C50 
II F ZA 43 Cervix C53 
II F ZA 44 Corpus uteri C54, C55 
II F ZA 45 Ovary C56 
II F ZA 46 Prostate C61 
II F ZA 47 Bladder C67 
II F ZA 48 Kidney C64-C66, C68 
II F ZA 49 Brain C71 
II F ZA 50 Lymphoma + multiple myeloma C81-C90, C96 
II F ZA 51 Leukemia C91-C95 
II F ZA 52 Other malignant neoplasms C17, C23-C24, C26, C30-C31, C37-C39, C45, C48, C51-C52, C57-C58, C60, C62-C63, C69-C70, C72-C75 
     III defined cancers C76-CBO, C97 
      
II G ZA 53 Other neoplasms D00-D48 
      
II H ZA 54 Diabetes Mellitus E10-E14 
      
II I   Endocrine and metabolic disorders D55-D63, D65-D89, E03-E07, E15-E34, E65-89 
II I ZA 55 Albinism E70.3 
II I ZA 56 Other endocrine and metabolic D55-D63, D65-D89, E03-E07, E15-E16, E20-E34, E65-E68, E71- E89 
      
II J   Mental disorders F10-F99 
II J ZA 57 Alcohol dependence F10 
II J ZA 58 Drug use F11-F16, F18-F19 
II J ZA 59 Schizophrenia F20-F29 
II J ZA 60 Unipolar F32-F33 
II J ZA 61 Bipolar F30-F31 
II J ZA 62 Anorexia nervosa F50 
II J ZA 63 Neurotic disorders F40-F42 
II J ZA 64 Hyperkinetic Syndrome of childhood F90 
II J ZA 65 Adjustment reaction (PTSS) F43 
II J ZA 66 Mental Disability F70-F79 
II J ZA 67 Other mental disorders F17, F34-39, F44-F48, F51-F59, F60-F69, F80-F89, F91-F98, F99 
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II K   Nervous system disorders F01-F09, G03-G99 
II K ZA 68 Alzheimer and other dementias F01-F09, G30-G31 
II K ZA 69 Parkinson's disease G20-G21 
II K ZA 70 Multiple sclerosis G35 
II K ZA 71 Epilepsv G40-G41 
II K ZA 72 Encephalitis and brain abscess G04, G06, G09 
II K ZA 73 Other nervous system disorders G08, G10-G12, G23-25, G36-G37, G43-G47, G50-G58, G60-G64, G70-G72, G80-G83, G90-G98 
      
II L   Sense Organs H00-H13, H15-H59, H60-H62, H68-H95 
II L ZA 74 Glaucoma H40 
II L ZA 75 Cataracts H25-H26 
II L ZA 76 Other visual disorders H00-H21, H27-H35, H42-H59 
II L ZA 77 Hernia loss and other ear disorders H60-H62, H68-H95 
      
II M   Cardiovascular 100-126, 128-184, 186-199, J81 
II M ZA 78 Rheumatic heart disease I01-I09 
II M ZA 79 Ischaemic heart disease I20-I25 
II M ZA 80 Stroke I60-I69 
II M ZA 81 Inflammatory heart disease I30, I33, 138, I40, I42 
II M ZA 81a Peri- endo myocarditis I30, I33, I38, I40 
II M ZA 8I b Cardiomyopathy I42 
II M ZA 82 Hypertensive heart disease I10-I13 
II M ZA 83 Non-rheumatic valvular disease I34-I37 
II M ZA 84 Pulmonary embolism I26 
II M ZA 85 Aortic aneurysm I71 
II M ZA 86 Peripheral vascular disorders I72- I78, I80-I84, I86-I89 
II M ZA 87 Other cardiovascular I00, I28, I3I, I44-I45, I95-I99 
     III-defined cardiovascular I46-I49, I50-I5I, I70, J81 
     Heart failure etc I46-I49, I50-I51, J81 
     Atherosclerosis I70 
      
II N   Respiratory I27, J30-J80, J82-J86, J92-J99 
II N ZA 88 COPD J40-J44, 127 
II N ZA 89 Asthma J45-46 
II N ZA 90 Aspiration pneumonia! lung abscess/emphysema J69, J85-J86 
II N ZA 91 Other respiratory J30-J39, J47, J60-J68, J70, J80, J82-J84, J92-J98 
      
II O   Digestive K20-K38, K40-K63, K65-K93, I85 
II O ZA 92 Peptic ulcer K25-K28 
II O ZA 93 Appendicitis K35-K37 
II O ZA 94 Noninfective gastroenteritis and colitis K50-K52 
II O ZA 95 Cirrhosis of liver K70, K74, K76, I85 
II O ZA 96 Hepatic failure K72 
II O ZA 97 Gall bladder disease K80-K83 
II O ZA 98 Diseases of the pancreas K85 K86 
II O ZA 99 Other digestive K20-K22, K29-K31, K38, K40-K46, K55-K66, K71, K73, K75, K90-K91 
     III defined K92 
      
II P   Genitourinary N00-N50, N60-N64, N75-N98 
II P ZA 100 Nephritis/nephrosis N00-N19 
II P ZA 101 Benign prostatic hypertrophy N40 
II P ZA 102 Other genito-urinary N20-N23, N25-N39, N41-N50, N60-N64, N75-N98 
      
II Q ZA 103 Skin disease L00-L98 
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II R   Musculo-skeletal M00-M99 
II R ZA 104 Rheumatoid arthritis M05-M06 
II R ZA 105 Osteoarthritis M15-M19 
II R ZA 106 Other musculo-skeletal M00-M02, M08, M10-M13, M20-M99 
      
II S   Congenital abnormalities Q00-Q99 
II S ZA 107 Neural tube defects Q00-Q07 
II S ZA 108 Cleft lip/palate Q35-Q37 
II S ZA 109 Congenital heart disease Q20-Q28 
II S ZA 110 Congenital disorders of GIT Q38-Q45 
II S ZA 111 Down syndrome and other chromosomal anomalies Q90-Q99 
II D ZA 112 Fetal alcohol syndrome Q86.0 
II S ZA 113 Other congenital abnormalities Q1 0-Q18, Q30-Q34, Q50-Q56, Q60-Q64, Q65-Q79, Q80-Q85, Q87 
     III defined Q89 
      
II T   Oral conditions K00-K14 
II T ZA 114 Dental caries K02 
II T ZA 115 Periodontal disease K05 
II T ZA 116 Other oral health K00-K01, K03-K04, K06-K14 
      
II U   Cot death R95, R96-R98 < 12 MTHS 
II U ZA 117 Cot death R95, R96-R98 < 12 MTHS 
  
  
  
   III defined 
R00-R09, R10-R19, R20-R23, R25-R29, R30-R39,R40-R46, 
R47-R49, R50-R69, R70-R79, R80-R82, R83-R94, R96-R98, 
> 12 months, R99 
      
III    Injuries V01-V99, W00-W99, X00-X99, Y00-Y98 
      
III V   Unintentional V00-V99, W00-W99, X00-X59, Y40-Y86, Y88 
III V ZA 118 Road traffic accidents V01-V04, V06, V09-V8,0 V8,7 V89, V99 
III V ZA 119 Other transport accidents V05, V81-V86, V88, V90-V94, V95-V98 
III V ZA 120 Mining accidents Y37 
III V ZA 121 Poisoning X40-X49 
III V ZA 122 Surgical / medical misadventure Y60-Y69, Y70-Y82, Y83-Y84, Y88 
III V ZA 123 Falls W00-W19 
III V ZA 124 Fires X00-X09 
III V ZA 125 Natural and environmental factors W53-W64, X20-X29, X30-X39, X50-X57 
III V ZA 126 Drowning W65-W74 
III V ZA 127 Suffocation and foreign bodies W75-W84 
III V ZA 128 Other unintentional injuries specified W20-W49, W50-W52, W85-W99, Y40-Y59, X10-X19, X58, Y38, Y39 
    III defined YB5-YB6 
    III defined transport YB5 
    III defined other unintentional X59, YB6 
      
III W   Undetermined whether intentional or unintentional Y10-Y34, Y87, Y89 
      
III X   Intentional injuries X60-X99, Y00-Y09, Y35-Y36 
III X ZA 129 Suicide and self-inflicted X60-X84 
III X ZA 130 Homicide and violence X85-Y09 
III X ZA 130a with firearm X93-X95 
III X ZA 130b without firearm X85-X92, X96-X99, Y00-Y08 
III X ZA 131 War / Legal intervention Y36, Y35 
    III defined Y09 
 
   
 36 
8.0 REFERENCES 
1. Ras GJ, Simson IW, Anderson R, et al. Acquired immunodeficiency 
syndrome. A report of 2 South African cases. S Afr Med J 1983; 64(4):140-
142. 
2. Maartens G, Wood R, O'Keefe E, Byrne C. Independent epidemics of 
heterosexual and homosexual HIV infection in South Africa-survival 
differences. QJM 1997; 90(7):449-454. 
3. Ijsselmuiden CB, Steinberg MH, Padayachee GN, et al. AIDS and South 
Africa - towards a comprehensive  strategy. S Afr Med J 1988; 73:455-460. 
4. McIntyre J. HIV/AIDS in South Africa - a relentless progression? S Afr Med 
J 1996; 86:27-28. 
5. Smith A. HIV/AIDS in KwaZulu-Natal and South Africa. AIDS Anal Afr 2000; 
11:6-9. 
6. Botha J, Bradshaw D. African vital statistics - a black hole? S Afr Med J 
1985; 67:977-981. 
7. Küstner HGV, Swanevelder JP, van Middelkoop A. National HIV 
surveillance in South Africa 1990-1992. S Afr Med J 1994; 84(4):195-200. 
8. Stuart J. Under-reporting of AIDS. S Afr Med J 1993; 83:689. 
9. Küstner HGV, Swanevelder JP, Van Middelkoop A. National HIV 
surveillance in South Africa 1993-1995. S Afr Med J 1998; 88:1316-1320. 
10. Swanevelder JP, Küstner HGV, van Middelkoop A. The South African HIV 
epidemic, reflected by nine provincial epidemics, 1990-1996. S Afr Med J 
1998; 88:1320-1325. 
11. AIDS epidemic update. Geneva: UNAIDS; 2000. 
12. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there 
a difference in median time to AIDS and survival compared with that in 
industrialized countries? Aids 2002; 16:597-603. 
13. Zaba B, Whiteside A, Boerma JT. Demographic and socioeconomic impact 
of AIDS: taking stock of the empirical evidence. Aids 2004; 18(suppl 2):S1-
S7. 
14. Porter K, Zaba B. The empirical evidence for the impact of HIV on adult 
mortality in the developing world: data from serological studies. Aids 2004; 
18 Suppl 2:S9-S17. 
15. Urassa M, Boerma JT, Isingo R, et al. The impact of HIV/AIDS on mortality 
and household mobility in rural Tanzania. Aids 2001; 15(2017-2023). 
16. Sewankambo NK, Gray RH, Ahmad S, et al. Mortality associated with HIV 
infection in rural Rakai District, Uganda. Aids 2000; 14:2391-2400. 
17. Crampin AC, Floyd S, Glynn JR, et al. Long-term follow-up of HIV-positive 
and HIV-negative individuals in rural Malawi. Aids 2002; 16:1545-1550. 
   
 37 
18. Todd J, Balira R, Grosskurth H, et al. HIV-associated adult mortality in a 
rural Tanzanian population. Aids 1997; 11:801-807. 
19. Senkoro KP, Boerma JT, Klokke AH, et al. HIV incidence and HIV-
associated mortality in a cohort of factory workers and their spouses in 
Tanzania, 1991 through 1996. J Acquir Immune Defic Syndr 2000; 
23(2):194-202. 
20. Blacker J. The impact of AIDS on adult mortality: evidence form national 
and regional statistics. Aids 2004; 18(S2):S19-S26. 
21. Feeney G. The impact of HIV/AIDS on adult mortality in Zimbabwe. Popul 
Dev Rev 2001; 27(4):771-780. 
22. Tollman SM, Kahn K, Garenne M, Gear JS. Reversal in mortality trends: 
evidence from the Agincourt field site, South Africa, 1992-1995. Aids 1999; 
13(9):1091-7. 
23. Hosegood V, Vanneste AM, Timǽus IM. Levels and causes of adult 
mortality in rural South Africa: the impact of AIDS. Aids 2004; 18(4):663-71. 
24. Dorrington R, Bourne D, Bradshaw D, et al. The impact of HIV/AIDS on 
adult mortality in South Africa. Technical Report.  Burden of Disease Unit, 
Medical Research Council. 2001  [cited 14 June 2006]; Available from: 
http://www.mrc.ac.za/bod/ 
25. Dorrington RE. ASSA600: An AIDS model of the Third Kind? Transactions 
of the Actuarial Society of South Africa 1998; 13(1):99-153. 
26. Anderson BA, Phillips HE. Adult mortality (age 15-64) based on death 
notification data in South Africa: 1997-2004. Pretoria: Statistics South 
Africa; 2006. Report No.: 03-09-05. 
27. Groenewald P, Bradshaw D, Dorrington R, et al. Identifying deaths from 
AIDS in South Africd: an update. Aids 2005; 19:744-745. 
28. Williams B, Campbell C. Mines, migrancy and HIV in South Africa - 
managing the epidemic. S Afr Med J 1996; 86:1249-1251. 
29. Ijsselmuiden CB, Padayachee GN, Mashaba W, et al. Knowledge, beliefs 
and practices among black goldminers relating to transmission of human 
immunodeficiency virus and other sexually transmitted diseases. S Afr Med 
J 1990; 78:520-523. 
30. Evian C, Fox M, MacLeod W, et al. Prevalence of HIV in workforces in 
southern Africa, 2000 - 2001. S Afr Med J 2004; 94:125-130. 
31. Stevens W, Apostolellis A, Napier G, et al. HIV/AIDS prevalence testing - 
merits, methodology and outcomes of a survey conducted at a large mining 
organisation in South Africa. S Afr Med J 2006; 96:134-139. 
32. Corbett EL, Churchyard G, Charalambos S, et al. Morbidity and mortality in 
South African gold miners: impact of untreated disease due to human 
immunodeficiency  virus. Clin Infect Dis 2002; 34:1251-1258. 
33. Glynn JR, Sonnenberg P, Nelson G, et al. Survival from HIV-1 
seroconversion in Southern Africa: a retrospective cohort study in nearly 
2000 gold-miners over 10 years of follow-up. Aids 2007; 21:625-632. 
   
 38 
34. Moore D. The AIDS threat and the private sector. Aids Analysis Africa 1999; 
9:1-2. 
35. International Statisitical Classification of Diseases and Related Health 
Problems, tenth revision: World Health Organisation; 1993. 
36. WHO. Interim proposal for a WHO staging system for HIV infection and 
disease. Wkly Epidem Rec 1990; 65:221-224. 
37. Bradshaw D, Groenewald P, Laubscher R, et al. Initial burden of disease 
estimates for South Africa, 2000. Cape Town: South African Medical 
Research Council; 2003. 
38. Stata Statistical Software, Version 8. 2005. StataCorp. College Station, TX 
39. Bradshaw D, Nannan N, Laubscher R, et al. South African National Burden 
of Disease Study 2000: Estimates of Provincial Mortality. Cape Town: 
South African Medical Research Council; 2004. 
40. Dorrington R, Bradshaw D, Bourne D. Two steps forward, one step back: 
Comment on adult mortality (age 15-64) based on death notification data in 
South Africa for 1997-2001. S Afr Med J 2006; 96:1028-1032. 
 
 
